The Federal Trade Commission has filed a lawsuit against Hims & Hers, a telehealth company, accusing it of sharing sensitive medical information from its customers with major advertisers, including Meta and Snap. This practice allegedly exposed potentially identifying health data without proper consent, raising serious privacy concerns among patients and regulators alike.
Hims & Hers operates an online platform offering various health and wellness products and services, often catering to sensitive areas such as sexual health, mental wellness, and dermatology. Customers trust the company to protect the confidentiality of their medical information, which is protected under federal privacy laws.
According to the FTC complaint, Hims & Hers transferred data—including details about patients’ medical conditions and treatments—to advertising networks to help target ads more precisely. The lawsuit alleges this was done without adequately informing users or obtaining their clear permission, leading to potential violations of patient privacy and data protection regulations.
The case highlights the complex balance between personalized marketing in digital health services and the obligation to safeguard sensitive health information. Patients could be at risk if their medical data are used in ways they did not expect, possibly affecting their privacy and trust in telehealth providers.
Going forward, the lawsuit could have significant implications for how telehealth companies handle user data, potentially leading to stricter enforcement of privacy laws and new standards for transparency in patient data use. Consumers and healthcare providers will be watching closely as the case progresses to understand the evolving boundaries of health data privacy in the digital age.